Michael R. Dougherty Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc.

Stock Information for BioSig Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.